Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred Aslan currently holds 1,535,082 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Aslan has been a net seller of ARTV stock. They have purchased $0 and sold $507.5K worth of shares.
Fred Aslan's most recent insider trade was on May 19, 2026, when they sold 27,116 shares at $9.01 per share.
Fred Aslan serves as Executive at Artiva Biotherapeutics, Inc. (ARTV). They have executed 11 insider transactions totaling $507.5K over their tenure at the company.
Fred Aslan holds the position of Executive at Artiva Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Fred Aslan has shown a selling trading pattern, with $0 in total purchases and $507.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fred Aslan was on May 19, 2026, when they sold $244.3K worth of ARTV shares. This transaction involved 27,116 shares at $9.01 per share.
Fred Aslan currently owns 1,535,082 shares of Artiva Biotherapeutics, Inc. (ARTV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred Aslan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred Aslan has 11 Form 4 filings on record as an insider at Artiva Biotherapeutics, Inc..
Set alerts for Fred Aslan and 40,000+ other insiders.